This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing the pediatric GHD treatment landscape with current prescribers of Skytrofa to better understand trends of use in clinic
Ticker(s): ASNDWho's the expert?
Institution: CHOP
- Professor of Clinical Pediatrics (Endocrinology) & Director of the Neuroendocrine Center in the Division of Endocrinology and Diabetes at Children's Hospital of Philadelphia.
- Manages ~300 patients with pediatric growth hormone deficiency; has prescribed Skytrofa.
- Research focuses on Neuroendocrinology with a concentration on disorders of the pituitary gland and diabetes insipidus.
Interview GoalThis interview will focus on Skytrofa in pediatric growth hormone deficiency and gain a better understanding of trends of use in the clinic & experience from current prescribers of the medication.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
